Hep C Drugs Pose Risk of Drug-Drug Interactions

December 28, 2015 Individuals taking the newest hepatitis C virus (HCV) treatments are often at risk of clinically significant drug-drug interactions (DDIs) with other medications they are taking, Reuters Health reports. Publishing their findings in Clinical Infectious Diseases, researchers studied 146 people with hep C who were recruited after the…

Read More

High Marks for Merck’s Hep C Treatment in Those With HIV

December 23, 2015 Merck’s investigational hepatitis C virus (HCV) treatment grazoprevir/elbasvir cured high rates of the virus among individuals coinfected with HIV, aidsmap reports. Final results from the Phase III C-EDGE Coinfection study of the fixed-dose combination tablet of the NS3/4 protease inhibitor grazoprevir and the NS5A inhibitor elbasvir were…

Read More

International Institute for Scientometric Studies (IISS)

International Institute for Scientometric Studies  (IISS) Scientometric emphasizes on investigations in which the development and mechanism of science are studied by means of mathematical (statistical) methods. The institute will provide the scientists with important up-to-date information about events in scientometric and related fields. We concerned with the quantities features and…

Read More

Biocon introduces advanced therapy to treat Hepatitis C

December 24, 2015 Biotechnology major Biocon today launched advanced novel therapy for the treatment of Hepatitis C at low cost. CIMIVIR-L, a fixed dose combination of Ledipasvir 90 mg and Sofosbuvir 400 mg, will be made available to patients in India at a fraction of the global cost of the…

Read More

Hepatitis C infection may increase Parkinson’s risk

December 25, 2015 Hepatitis C, a liver infection caused by a virus, may increase the risk of developing Parkinson’s disease, a common degenerative brain disorder.  “Many factors clearly play a role in the development of Parkinson’s disease, including environmental factors,” said study author Chia-Hung Kao from China Medical University in…

Read More

Correctional Facilities Are Ideal Places to Fight Hepatitis C

December 21, 2015 Considering that more than 10 percent of Canadians with hepatitis C virus (HCV) are incarcerated in any given year, the country’s jails and prisons are excellent places to combat the virus. Researchers published a paper in the Canadian Journal of Public Health advocating for HCV-fighting efforts in…

Read More

Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-Analysis

Published: December 2015 Authors:Qin Wu ; Cong Wang ; En Qiang Chen ; Hong Tang ; Zhen Zhen Li ; and Xue Zhong Lei Source: hepatmon Abstract: Context: There is growing evidence that interferon lambda 4 (IFNL4) polymorphism is related to sustained virological response (SVR) in hepatitis C virus (HCV)…

Read More

Quest Diagnostics Will Automatically Confirm Positive Hep C Tests

December 16, 2015 The clinical testing company Quest Diagnostics will now automatically conduct confirmatory molecular tests following a positive serological hepatitis C virus (HCV) test result, MedPage Today reports. In the past, Quest and most other labs have waited for clinicians to order the molecular test, which typically would require…

Read More